Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1Classical hematology 1

Conditions

Venous Thromboembolism 3Neoplasms 2Venous Thrombosis 1Lung Neoplasms 1Esophageal Neoplasms 1

Interventions

Darbepoetin alfa 3Tinzaparin 2Epoetin Alfa 2Cisplatin 2sotorasib 1romiplostim 1pegfilgrastim 1continuous erythropoietin receptor activator 1Tretinoin 1Rivaroxaban 1Nadroparin 1Gemcitabine 1Fondaparinux 1Docetaxel 1Dalteparin 1Carboplatin 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Nadroparin × Classical hematology × Clear all
NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡